Viktor Kopylov, PhD, CFA
Macro strategist posting on USD/rates/PMIs that directly affect cross‑commodity pricing across energy, metals, and agriculture.
Kering Q1 Stabilizes; Buy Dips at €260
Macro: Kering Q1 stabilized; Jewelry & Eyewear offset Gucci. Key: N.A. strength, FX/disposals. Risks: geopolitics, Gucci lag, rich valuation. Trade: buy dips to €260 📈 — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
AI-Driven Tools Heighten Exchange Cyber Risk; Boost Defenses
Anthropic's Mythos and similar AI raise cyber risk for exchanges; firms accelerate defenses as automated vulnerability discovery scales. Trade: reduce exchange custody exposure. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
Buy Northwestern on Dips Despite Stretched Valuation
Macro: NorthWestern hits 52‑wk high on strong EPS, revenue beat and 26% 12m total return. Key: 21-yr dividend streak, Black Hills merger. Risk: stretched valuation. Insight: buy on weakness. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
Herbalife Issues $800M Notes, Boosts Credit Outlook
Herbalife plans $800M 2033 secured notes to refinance costlier debt and extend maturities. 78% gross margin, $253M FCF, S&P upgrade support credit. Risk: leverage. Trade accumulate on pullbacks. — Viktor Kopylov, PhD, CFA. More insights: t.me/si14Kopylov
Anavex Shows Promise, but EMA Hurdles Loom
Macro: autophagy links autism & Alzheimer’s. Key: Anavex blarcamesine restores autophagy; positive Phase IIb/III data. Risk: EMA pushback. Insight: speculative long, tight stop. 🔬 — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
Descartes AI Boosts Routes 30%, Still Overvalued
Descartes launches Fleet Data Intelligence with AI agent René; early deployments show up to +30% route density. Strong revenue/gross margins but P/E appears stretched. Trade: buy on pullback. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
QCOM Margins Squeezed; Hold Off New Longs Till June
QCOM: handset volumes fall; memory-price shock squeezes margins. Auto/IoT gain offsets but Apple modem exit and licensing risk persist. Trade: avoid new longs until June analyst day. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
Rezolve Secures $232M Deal, Targets $360M Guidance
Macro: AI-commerce consolidation. Rezolve (RZLV) investor call; $232M contracted for 2026, $360M guidance vs Commerce.com's weak base. Risk: approvals & execution. Trading insight: consider long RZLV pre-call. 📞 — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
BNY Mellon at $128.76 ATH, Buy Dips Target $140
BNY Mellon hits $128.76 ATH; YTD +67.7%. P/E17.3 PEG0.6 56y div $500m perp. Risk: softer fees, rising costs. Trade: Buy dips $120-125; target $140. — Viktor Kopylov, PhD, CFA. More insights: t.me/si14Kopylov
Cordel Secures District Line LiDAR Deal Amid Rail Digitisation Surge
Macro: urban rail digitisation accelerates; Cordel wins District Line LiDAR+AI rollout after Central Line success; key: TfL adoption and in‑tunnel geo‑location; risk: execution; trading insight: initiate a small long in CRDL on pullbacks. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
Peace‑talk Collapse Fuels Oil, Yields; USD Firm, Asia Soft
Macro: Peace‑talk collapse lifts oil & yields; USD firm, Asia soft. Drivers: Strait blockade, energy spike, tighter Fed. Risks: inflation, earnings. Trade: short EM equities vs USD. —V. Kopylov, PhD, CFA More insights: t.me/si14Kopylov
AbbVie’s Mirvetuximab Shows
AbbVie combo mirvetuximab posts 62.7% ORR; median DOR 11.2m. Efficacy boosts pipeline vs rich valuation and R&D hit. Trading insight: buy on pullback ahead of catalysts. 📈 — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
Hold Until BTC Closes Above $73,107 for Long
Macro: BTC stalls below $73,107 after rebound from ~$60k; momentum shows early fatigue. Key factors: RSI ~61, MACD still bullish, volume lacks expansion. Risk: failure → retrace toward $69k–$65k. Trade insight: wait for daily close >$73,107 to go long to...
Scale Small, Add Only to Winning Trades
Macro: markets favor trend & momentum; drivers: liquidity hunts, news pauses; risks: oversized entries, tight stops, averaging down. Trading insight: scale in small and add only to winners. — Viktor Kopylov, PhD, CFA. More insights: t.me/si14Kopylov
Apple’s $32B MacBook Neo TAM: Buy on Pullbacks
Macro: Apple targets $32bn TAM with MacBook Neo. Key factors: $499 ASP, $300–$800 segment, minimal cannibalization. Risk: low-margin mix and component cycles. Trading insight: Buy on pullbacks. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
